PCOS Hair: Facial Hair, Hair Loss & What Helps (Canada)
PCOS hair changes show up as two opposite-looking symptoms driven by the same hormone: unwanted facial and body hair (hirsutism) and thinning hair on the scalp (androgenic alopecia). Elevated androgens affect hair follicles differently depending on where they sit. They coarsen hair at the chin, jaw, and upper lip while miniaturizing follicles at the scalp's crown and part line. Hirsutism affects an estimated 65–75% of women with PCOS, scored clinically with the Ferriman-Gallwey system across nine body areas. Scalp thinning is reported in roughly one in five to one in two women with PCOS depending on the study population, and a clinician will typically check ferritin and thyroid function first to rule out other contributors before attributing it to androgens. What actually helps splits into two lanes: non-prescription physical options (laser hair removal and electrolysis for unwanted hair, volumizing and low-level light approaches for scalp density) and prescription options that target androgen levels or their effect at the follicle, which a licensed clinician considers individually. The underlying metabolic driver, insulin resistance, raises how much androgen is biologically available, which is why the lifestyle arc covered in PCOS treatment in Canada is relevant to hair outcomes, not just weight. For the mechanism connecting insulin and hormones more broadly, see our insulin resistance guide.
Naming note: In May 2026, PCOS was formally renamed polyendocrine metabolic ovarian syndrome (PMOS) by global consensus published in The Lancet. Everything in this article about hair symptoms and what helps applies identically under both names. See our PCOS-to-PMOS explainer for the rename context. This article uses "PCOS" because that remains the term most patients are searching for during the transition period.
Why PCOS affects hair in two opposite directions
If you have PCOS and you're dealing with new chin hair and a widening part at the same time, you're not imagining a contradiction. Both symptoms come from the same hormonal source: elevated androgens, primarily testosterone and DHEA-S, produced in excess by the ovaries and, in some cases, the adrenal glands.
What differs is how individual hair follicles respond to that androgen exposure, and the response is location-dependent. On the face, jaw, and chest, androgen-sensitive follicles that normally produce fine, barely visible vellus hair get pushed into producing coarse, pigmented terminal hair — that's hirsutism. On the scalp, the opposite happens: androgens shorten the growth phase of scalp follicles and progressively shrink them, a process called miniaturization, producing visibly thinner hair over time rather than thicker hair. Same hormone, same underlying condition, opposite cosmetic effect, because scalp and body follicles carry different genetic sensitivity to androgens.
This is also why hair symptoms are one of the clinical hyperandrogenism signs used in diagnosing PCOS in the first place, alongside irregular cycles and, on bloodwork, elevated free testosterone.
Take the free 3-minute quiz
PCOS facial hair: the chin, jaw, and upper lip pattern
Unwanted facial hair, often searched as PCOS facial hair, PCOS chin hair, or PCOS beard growth, is usually the first hair-related symptom women notice, sometimes years before a diagnosis. It follows a specific pattern because androgen-sensitive follicles aren't distributed evenly across the body.
Where it typically shows up. The chin and jawline are the most commonly affected areas, followed by the upper lip, and then the chest, lower abdomen, and inner thighs. A study grading hirsutism using the modified Ferriman-Gallwey system found terminal hair growth most prominent at the chin, upper lip, and lower abdomen, the same regions patients describe informally as "PCOS beard" territory. This clustering isn't random; it reflects where androgen receptor density on hair follicles is highest.
How clinicians measure it. The Ferriman-Gallwey score is the standard tool. A clinician rates hair growth from 0 (none) to 4 (extensive) across nine body regions: upper lip, chin, chest, upper and lower back, upper and lower abdomen, upper arm, and thighs. In general population studies, a total of 8 or higher defines hirsutism, with mild (8–16), moderate (17–24), and severe (above 24) tiers. The 2023 International Evidence-Based Guideline for PCOS recommends a lower, ethnicity-adjusted threshold instead, somewhere in the range of 4 to 6, because a flat threshold of 8 misses hirsutism in some ethnic groups and over-calls it in others. If your clinician scores you differently than a chart you found online, this is usually why.
The mechanism underneath it. Elevated ovarian androgen production is the direct driver, but it isn't the whole story. Androgen levels on bloodwork correlate only loosely with how severe hirsutism actually looks. Some women with modestly elevated testosterone have significant hair growth, and some with more elevated levels have relatively little. Individual follicle sensitivity, family history, and ethnicity all shape how a given androgen level translates into visible hair.
PCOS hair loss: androgenic scalp thinning
Scalp thinning, the "PCOS hair loss" side of the equation, is less discussed than facial hair but affects a meaningful share of women with PCOS. Reported prevalence varies widely by study population: a cross-sectional study of PCOS patients at a tertiary care centre found androgenic alopecia in about one in five patients, while some clinical reviews cite figures as high as one in two, depending on diagnostic criteria and how early in the disease course the population was assessed.
What the pattern looks like. PCOS-related scalp thinning follows what's clinically called female-pattern hair loss: diffuse thinning concentrated at the crown, a widening part line sometimes described as a "Christmas tree" pattern, and a frontal hairline that is usually preserved. That last point matters for distinguishing it from other causes. Review literature on female pattern hair loss contrasts this with frontal fibrosing alopecia, which causes progressive hairline recession and eyebrow loss, and with telogen effluvium, which produces more generalized, diffuse shedding without the crown-focused miniaturization pattern.
Why the workup matters before assuming it's PCOS. Hair loss has several common causes that overlap with the PCOS population, and a clinician typically rules these out, or treats them alongside the androgen picture, before assuming androgens are the sole driver. The standard checks include ferritin (low iron stores are a well-documented contributor to hair shedding even without anemia), thyroid function, and vitamin D, since deficiencies in any of these can independently worsen hair loss and are common enough in reproductive-age women that they're worth ruling out rather than assuming. If your ferritin or thyroid results come back abnormal, correcting those is usually addressed first or in parallel with the androgen-focused plan.
Does PCOS hair growth reverse?
This is the honest, unglamorous answer: partially, slowly, and it depends on which direction of hair change you're asking about.
Unwanted facial and body hair generally doesn't reverse on its own. Once a follicle has converted from producing fine vellus hair to coarse terminal hair, that conversion tends to be durable. Improving the underlying hormonal picture, whether through insulin sensitivity gains, weight change where excess weight is part of the picture, or a prescription option a clinician has assessed as appropriate, can slow or prevent new hair from converting, but it typically doesn't make already-established coarse hairs disappear. That's why the physical removal methods below remain part of the plan even when the hormonal picture is well-managed.
Scalp regrowth has more room to improve, but the timing matters. Hair follicles that are miniaturizing but not yet dormant can, in some cases, thicken again once androgen exposure is reduced and other contributors (ferritin, thyroid) are corrected. The earlier this is addressed relative to when thinning started, the better the odds tend to be — a follicle that has been miniaturizing for years has less capacity to recover than one caught early. There's no guarantee of visible regrowth, and no clinician or program should promise one; what's realistic is slowing further loss and, for some women, a partial improvement in density over months, not weeks.
See if Cloudcure is right for you
What actually helps with PCOS hair symptoms in Canada
Non-prescription and physical options
For unwanted facial and body hair, two methods have the most consistent track record and are both regulated as medical devices in Canada under the Radiation Emitting Devices Act:
- Laser hair removal. Targets melanin in the hair follicle and works best on the classic light-skin, dark-hair combination. It's less effective on blond, red, grey, or white hair, and less consistent on darker skin tones unless the clinic uses a device suited to that skin type. Health Canada's consumer guidance notes that a typical course of treatments produces roughly 30% permanent reduction, with the rest requiring maintenance sessions. It's rarely a one-and-done result. Results depend heavily on operator training and the device used, so confirming the clinic uses a Health Canada-licensed device is worth doing before booking.
- Electrolysis. Treats individual follicles with a fine probe and works regardless of hair or skin colour, which makes it the more reliable option for lighter or grey hair that laser can't target. It's slower, since each follicle is treated individually, and typically requires more sessions spread over a longer period. That per-follicle approach is why it's often described as the more thorough option for stubborn areas like the chin.
- Waxing, threading, and plucking remain the lowest-upfront-cost options and are widely available across Canada, but the ongoing cost adds up: repeat sessions every two to four weeks, indefinitely, versus a front-loaded series with laser or electrolysis. For women managing hirsutism as a long-term feature of PCOS rather than a one-off, that cost comparison is worth doing honestly.
For scalp density, the non-prescription lane is narrower but real: gentler styling that reduces traction on thinning areas, volumizing products and strategic parting, scalp micropigmentation for camouflage, and low-level light therapy devices, which some women use at home as an adjunct. The evidence for these is modest but they carry minimal risk. None of these change the underlying androgen picture; they manage appearance while the metabolic and hormonal side is addressed separately.
Prescription options
Beyond the physical and cosmetic approaches above, there are prescription options a clinician may consider that target androgen levels or their effect at the follicle. Whether one fits your situation depends on your labs, symptom severity, and whether pregnancy is a current consideration. It's a decision made individually with a licensed clinician, not a default add-on. For the full framework of where these fit into PCOS care, see PCOS treatment in Canada.
The metabolic root: why insulin resistance matters for hair symptoms too
Hair symptoms in PCOS aren't purely a hormone-in-isolation problem. Insulin resistance is a major reason androgen levels run high in the first place, and it independently worsens hirsutism severity even after accounting for measured androgens. A Korean cohort study cited in a review of hirsutism and PCOS found that insulin resistance, measured by HOMA-IR, was positively associated with Ferriman-Gallwey scores independent of biochemical androgen levels. That suggests insulin resistance influences hair symptoms through more than one pathway.
The mechanism: elevated insulin stimulates ovarian androgen production directly, and it also suppresses sex hormone-binding globulin (SHBG), the protein that binds testosterone and keeps most of it biologically inactive. Less SHBG means more free, biologically active testosterone circulating and reaching hair follicles — even when total testosterone on a lab report looks only modestly elevated.
This is why the same lifestyle arc that helps with PCOS weight and metabolic markers is genuinely relevant to hair outcomes, not a tangential add-on. A sustained 5–10% body-weight reduction, the evidence-based target for women who carry excess weight, improves insulin sensitivity, which in turn tends to raise SHBG and lower free androgen exposure over months. Resistance training and reducing refined-carbohydrate intake work through the same insulin pathway. None of this happens quickly; hormonal markers move over months, not weeks, and hair follicles respond even more slowly than bloodwork does.
The lean-PCOS caveat applies here too. PCOS occurs at a normal weight in a meaningful share of patients. The insulin resistance and androgen excess driving hair symptoms can be present regardless of BMI. For women in that group, weight loss is not the goal, and intentional weight loss can be counterproductive. The levers that matter are the same insulin-sensitivity-focused ones: resistance training, carbohydrate quality, and sleep, aimed at the metabolic picture rather than the scale. For the fuller mechanism connecting insulin resistance to PCOS symptoms broadly, see our insulin resistance guide.
How Cloudcure approaches PCOS hair symptoms
Hair symptoms rarely get addressed as part of a coherent plan in standard care. A family physician might treat the cycle irregularity, a dermatologist might treat the skin, and the hair symptoms sit in between, often left to be managed with over-the-counter approaches alone. Cloudcure's PCOS care program is built to close that gap by treating hair symptoms as one output of the same hormonal and metabolic picture driving the rest of PCOS.
Baseline workup includes total and free testosterone, DHEA-S, SHBG for a calculated free androgen index, ferritin, thyroid function, HbA1c, and fasting insulin, so hair symptoms are assessed against the actual hormonal and metabolic data rather than treated as a cosmetic issue in isolation.
A 12-month structured arc with monthly clinician follow-up and lab reviews at months 3, 6, and 12, tracking whether the insulin and androgen markers underneath hair symptoms are actually moving.
Coordination with dermatology or your existing care team happens when physical hair removal, scalp treatment, or a prescription option is part of the plan. We don't replace that care; we run the metabolic arc underneath it.
Membership is $99 per month and HSA- and HCSA-eligible across major Canadian benefits providers, consistent with the framework most structured medical weight-management programs in Canada operate within.
Start your eligibility check
The bottom line
PCOS hair symptoms, facial and body hair growth in some areas and scalp thinning in others, come from the same androgen excess acting on genetically different hair follicles, and insulin resistance is a major reason androgen levels run high in the first place. The Ferriman-Gallwey score gives hirsutism an objective baseline; ferritin and thyroid checks make sure scalp thinning isn't being misattributed. What actually helps splits into two timelines: physical removal or cosmetic management now, and the slower metabolic and hormonal work underneath it, with prescription options, where appropriate, layered in individually by a licensed clinician. Neither lane replaces the other — hair removal handles what's already there while the metabolic work shapes what comes next. If you're dealing with both sides of this at once, that's not a contradiction to untangle on your own. It's a single mechanism worth having a clinician actually map out. For the fuller PCOS picture, our PCOS resource hub links every guide we publish, starting with what PCOS is and how it's diagnosed.